SUPERIOR GROUP OF COMPANIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SUPERIOR GROUP OF COMPANIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	253	267	346	377	527	537	579	543	566	566
Cost of revenue	166	170	225	248	338	351	385	340	345	353
Gross profit	87	96.4	122	129	189	186	193	204	221	213
Selling, general and administrative	65.1	70.6	96.7	107	137	142	176	184	200	199
Interest expense	0.69	0.8	3.21	4.4	2	1.22	4.89	9.72	6.36	5.14
Pre-tax income	19.9	24.8	21.4	15.3	51.5	33.1	-38	9.77	14.3	8.25
Income tax	5.26	9.76	4.42	3.22	10.4	3.69	-6.07	1	2.29	1.25
Net income	14.6	15	17	12.1	41	29.4	-32	8.77	12	7
EPS, basic	1.04	1.04	1.14	0.81	2.72	1.91	-2.03	0.55	0.75	0.47
EPS, diluted	0.98	0.99	1.10	0.79	2.65	1.83	-2.03	0.54	0.73	0.46
Shares, basic (weighted)	14.1	14.5	14.9	14.9	15.1	15.4	15.8	16	16	15
Shares, diluted (weighted)	14.9	15.1	15.5	15.3	15.5	16.1	15.8	16.2	16.5	15.3
Dividend per share	0.34	0.37	0.39	0.40	0.40	0.46	0.54	0.56	0.56	0.56

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	3.65	8.13	5.36	9.04	5.17	8.94	17.7	19.9	18.8	23.7
Receivables	41.8	50.6	64	79.7	102	107	105	103	95.1	104
Inventory	69.2	65	73.4	73.4	89.8	121	125	98.1	96.7	97.5
Other current assets	7.21	11	6.65	9.93	11	19.2	14.2	9.19	10.8	13.3
Total current assets	125	137	197	212	248	299	318	279	273	288
Property, plant and equipment	27.5	26.8	28.8	32.8	36.6	49.7	51.4	46.9	41.9	37.4
Lease right-of-use assets				5.45	3.83	8.25	9.11	17.9	15.6	12.6
Goodwill	11.3	16	34	36.3	36.1	39.4	0	0	2.3	2.58
Intangible assets			66.3	62.5	58.7	60.4	55.8	51.2	51.1	47.3
Other non-current assets	3	7.56	8.83	10.1	10.1	13.2	12	14.8	17.4	19.4
Total assets	197	219	335	359	394	470	457	422	415	422
Accounts payable	13.5	19.8	24.7	33.3	39.3	52.3	42.1	50.5	50.9	48.3
Accrued liabilities	5.6	7.85	6.48	7.29	26.3	17.4	14.3	14.6	18.5	15
Deferred revenue		0.47	0.44	1.82	5.07	8.8	2.21	5.35	2.83	10.7
Short-term debt	5.89	6	6	15.3	15.3	15.3	3.75	4.69	5.63	6.56
Total current liabilities	31.9	41.2	46.4	69.4	105	111	85.2	101	102	108
Long-term debt	36.2	32.9	112	104	72.4	101	152	88.8	80.4	87.1
Lease liabilities				2.38	1.6	3.73	3.94	12.8	10.5	7.94
Other non-current liabilities			3.65	4.92	6.54	9.21	8.54	8.78	9.38	10.2
Total liabilities	86.3	94	184	201	202	243	264	225	216	229
Total debt	42.1	38.9	118	120	88.1	117	156	94.4	86	94.1
Paid-in capital	42.4	49.1	55.9	57.4	61.8	69.4	72.6	77.4	84.1	84.6
Retained earnings	74.3	83.1	103	108	142	164	123	122	120	113
Other comprehensive income								-2.29	-5.36	-4.7
Shareholders' equity	111	125	151	158	192	227	193	198	199	193
Total equity	111	125	151	158	192	227	193	198	199	193
Total liabilities and equity	197	219	335	359	394	470	457	422	415	422
Shares outstanding	14.5	15.1	15.2	15.2	15.4	16.1	16.4	16.6	16.5	15.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	14.6	15	17	12.1	41	29.4	-32	8.77	12	7
Depreciation and amortization	4.94	5.65	7.91	8.27	8.13	9.29	13	14	13.2	12.4
Stock-based compensation	1.64	1.66	2.26	1.48	2.53	4.01	4.29	3.79	4.27	5.26
Deferred income tax	-1.01	4.33	-0.63	-1.41	-4.99	-2.72	-12.4	-1.64	-1.58	-0.85
Change in receivables	-7.24	-4.73	-4.89	-17.1	-29.3	-2.58	0.68	1.05	7.98	-10.8
Change in inventory	-5.43	4.25	2.43	-4.98	-16.8	-24.5	-15.9	24.7	-1.03	-2.8
Change in payables	0.09	3.29
Cash from operations	12	22.7	19.9	20	41.4	17.1	-2.6	78.9	33.4	19.7
Capital expenditures	-7.39	-4.25	-4.87	-9.67	-11.9	-17.7	-11	-4.96	-4.44	-3.95
Acquisitions	-15.2	-7.99	-85.6	0	0	-16.4	-11.2	0	-4	0
Cash from investing	-22.5	-9.38	-90.5	-9.67	-6.57	-34.1	-17.4	-5.51	-8.44	-3.95
Debt issued	125	74.4	206	165	202	251	332	6
Debt repaid	-107	-77.6	-127	-164	-234	-223	-293	-3.75	-4.69	-5.63
Stock issued	1.5	1.87	0.73	0.28	1.93	2.7	0.73	0.18	1.13	0.24
Share buybacks	-0.71		-2.91	-1.69	-0.5	0	0	0	-7.42	-10.1
Dividends paid	-4.71	-5.27	-5.84	-6.05	-6.11	-7.24	-8.65	-9.19	-9.28	-8.91
Cash from financing	13.1	-8.92	68.1	-6.71	-38.4	21	28.8	-71.6	-24.5	-11.8
Net change in cash	2.61	4.48	-2.77	3.68	-3.87	3.76	8.79	2.17	-1.13	4.93
Free cash flow	4.6	18.5	15	10.3	29.5	-0.62	-13.6	74	29	15.8
Interest paid	0.69	0.73	2.72	3.98	1.49	1.3	4.77	9.59	5.92	5.66
Income taxes paid	5.08	7.17	1.09	7.15	13.4	14.6	1.35		2.3	1.62

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.36 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	37.6%	Gross profit / revenue.
Pre-tax margin	1.6%	Pre-tax income / revenue.
Net margin	1.4%	Net income / revenue.
FCF margin	7.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.4%	Cash from operations / revenue.
Effective tax rate	15.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.0%	Net income / average total assets.
SG&A / revenue	34.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.6%	Capital expenditures / revenue.
D&A / revenue	2.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-41.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-29.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-37.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-29.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-41.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-13.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-45.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-11.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	1.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	7.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-3.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-7.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.61x	Current assets / current liabilities.
Quick ratio	1.15x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.40x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.1%	Total debt / total assets.
Liabilities / assets	52.7%	Total liabilities / total assets.
Net debt	$50.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$173.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	10.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$148.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.43x	Revenue / average total assets.
Fixed asset turnover	17.0x	Revenue / average property, plant and equipment.
Inventory turnover	4.13x	Cost of revenue / average inventory.
Days inventory	88 days	365 x average inventory / cost of revenue.
Receivables turnover	6.04x	Revenue / average receivables.
Days sales outstanding	60 days	365 x average receivables / revenue.
Days payables	52 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	97 days	Days inventory + days sales outstanding - days payables.
FCF conversion	567.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	6.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.53	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$38.12	Revenue / diluted weighted shares.
FCF per share	$3.01	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.22	Cash from operations / diluted weighted shares.
Book value per share	$12.15	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9.34	Tangible book value / shares outstanding.
Cash per share	$1.76	(Cash + short-term investments) / shares outstanding.
Payout ratio	108.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	19.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	8.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$213.0M	Share price x shares outstanding.
Enterprise value	$263.1M	Market cap + total debt - cash - short-term investments.
P/E	26.3x	Market cap / net income. Only when net income is positive.
P/S	0.37x	Market cap / revenue.
P/B	1.10x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.44x	Market cap / tangible book value, when positive.
P/FCF	4.64x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	4.34x	Market cap / cash from operations, when positive.
EV/Sales	0.45x	Enterprise value / revenue.
EV/FCF	5.73x	Enterprise value / free cash flow, when both are positive.
FCF yield	21.5%	Free cash flow / market cap.
Earnings yield	3.8%	Net income / market cap (the inverse of P/E).
Dividend yield	4.1%	Dividends paid over the period / market cap.
Shareholder yield	5.8%	(Dividends paid + share buybacks) / market cap.

What was SUPERIOR GROUP OF COMPANIES, INC.'s revenue in fiscal 2025?

SUPERIOR GROUP OF COMPANIES, INC. reported revenue of $566.2M for fiscal 2025, 0.1% higher than the year before.

Was SUPERIOR GROUP OF COMPANIES, INC. profitable in fiscal 2025?

Yes. Net income was $7.0M, a net margin of 1.2%.

How much free cash flow did SUPERIOR GROUP OF COMPANIES, INC. generate in fiscal 2025?

Cash from operations of $19.7M minus capital expenditures of $3.9M left free cash flow of $15.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SUPERIOR GROUP OF COMPANIES, INC.